<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Cranham Health Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Cranham Health Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1106000AM&amp;denomIds=11.6&amp;selectedTab=summary">Tafluprost and timolol</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>26</td>
      <td>Treatment of glaucoma</td>
      <td>443</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.19</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1106000AMBBAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Taptiqom 15micrograms/ml / 5mg/ml eye drops 0.3ml unit dose : 21</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1106000AMAAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Tafluprost 15microg/Timolol 5mg/ml eye dps 0.3ml : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0407010B0&amp;denomIds=4.7.1&amp;selectedTab=summary">Aspirin</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>16</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>850</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0407010B0AAAEAE&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Aspirin 300mg dispersible tablets : 16</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1108010L0&amp;denomIds=11.8.1&amp;selectedTab=summary">Liquid paraffin</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>22</td>
      <td>Tear deficiency, eye lubricant/astringent</td>
      <td>189</td>
      <td>0.12</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>6.23</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHCUlEQVR4nO3dbawcVR3H8e9pmz4QtFolJgZ0ogKJCCoaSC0x0BiiDiENCCaUEF+VxkJsxNLRGgVBHDX4kIigogjGACIEkDEgCAbe3MiTJCJCipkUIqYhty2l1hbpnxdnLswdZu9D7zk79975fZLJ7N15+J/Zu789u7Mzs87MEJF+WNB1A0RkeBR4kR5R4EV6RIEX6REFXqRHFHiRHlHgRXpEgRfpEQVepEcUeJEeUeBl+JzT8dwdGUrgk6w4JcmKbBi1RGSwYfXwXwU2JVlx9JDqiUiL6IFPsuIDwOHABuB7seuJyGDD6OHPB34G3AwclmTF6iHUFJEWUQOfZMVS4PPADWWeGvBl4MokKxbGrCsi7WL38J8D7ivzdAdAmacjwFPAFyLXFZEWsQO/HrimcV8GbEmy4i2Ra4tIQ7TAJ1lxLLAMeLh+f5mn24Abgc2xaotIu5g9/Hrgmuqze1MOrE2y4j0R64tIQ5TAJ1lxKHA6vid/kzJPdwPfBr4To76ItIvVw58D3FHm6csTzHMdcEySFSdGaoOINAQPfJIVDv92/uqJ5ivz9FXgIuCH1TIiElmMHv4E4OUyT5+cbMYyT/8MvAicHaEdItIQI/BtX8VNZBNwRZIV747QFhGpCRr4JCtWAKuBW6e6TJmnTwPfAG5PsuKQkO0RkfFC9/DnATeVebpvOguVefpb4G7g+iQrdI6+SCTBwlXteFuHP1HmYFwCHAAuDdUmERkvZG96MrCtzNN/HczCZZ4ewB9jf2qSFecGbJeIVEIGfgOTfBU3mTJP9wJrgG8mWbEqSKtE5HUhA38ccNdMV1Lm6QvAWcBvkqx434xbJSKvCxn4q6qDaWaszNO/ARvxe+6Xh1iniIQN/HUB10WZp3cC1wM36+s6kTCCBb7M05dCravmB8AI8FiSFadEWL9Irziz2X+J8CQrjgeuxZ9bf3GZp7s6bpLMhHOGmc6f6MCcOMilzNPHgBOBbcCjSVakHTdJZE6aEz18XZIVHwR+CTwLbCzz9MWOmyTTpR6+M3Mu8ADVVW8vBL4E/Bj4dZmnO7ttlUyZAt+ZORn4MUlWvBe4AH8p7LuBn1Zf6clspsB3Zk4HfkySFcvwod8A7AeuAn5f5un+Thsm7RT4zsyLwNclWXEC8EX8sf234E/V/Wt1rL7MBgp8Z+Zd4MckWfFO/A9hnAkcCfwBuA14qMzT/3fZtt5T4DszbwNfV12Y43TgDOCjwD34F4CHgRcGXEpbYlHgO9OLwNdVv3jzWeAz+PC/A/g78HhteFYfASJS4DvTu8A3VT94+SF8+MeGBHgeeBp4pjZ+pszTPd20dB5R4DvT+8C3qS6zdThwNHBUbXwUsAj4DzDaGHa03DcK7NC3BQ0KfGcU+Gmq3hEcBqyoDW9v/N2cthh4BdgJ7MN/ddg23g3sAl5qGe8DXm0MB6rxfmAv8L9qvG9W75dQ4DujwA9JkhWLgeX48C9pGS8FDq3mWQ68tXZ7bLmFjWFBNV5cLb+sGpbUShtvfqFoe9EY2rTyu6ddkmy+62sHsc6x/SquMZ7qfdOdv8ka46neZwdxe8rzlnn6xwHtbdkCsyADsC7UulR39tRU3flVM+TZcusCrkt1Z09N1Z1HNefE6bEiEoYCL9IjIQP/84DrUt3ZU1N151FN7aUX6RG9pRfpkUXTmdk590ngE8B2M/uVc+4M4P3AVuBJYC3+iLOfAJdXi20xsxldr36SujurabuBB/F7O/9kZrfPpOYU6hrwceB+4AngK8BeM/tW5LrPASdV068g0Pa21FwDfNrM1tenAXcQd1vrddcAH8Ef1vxfqsfbzO6PXHcjvjN8EH/Q01pgh5n9KHLd1fgfdDkGKAi4vWOm28OvNLMcf6QZwJFm9n38IacpPuRLgA8D9wL3VbdnamBdM3sAyPEnwezHBz/Udewn2t49+KPnluLPvb8W+LdzbkXMumb2CPA74AHCbu+4mtULSNky7WQibmu9bnX7SuAIxj/eIUy0vaP4g5kWMf55HbVuFewR/Itq6O0Fph/45gf+Ye0AmKzuxcAvzOwfZrYZCPUTVQPrmtm9ZnYpcHygWlOqWzkTuDXw9k70v4z5fx64bufcQvz/9uoIj/fAumZ2QxXKTwWqNaW6lVOBe2I9v6b1lh4Ycc5tBkadcx8DtjrnNuHPJnsK2IJ/S/8EcFm1zNcDtHNgXefc+fgn/Ern3D+B0/CHm4YwUd2T8L3dLuAvwEX4t7mjMetW099lZtudc8cSbnubNQ8BVjnnVtWmbSf+ttbrpvjn6Ern3B7eeLxDmKju2/Bvp7cCj/DG8zp23RFggZm90nh+BaO99CI9or30Ij2iwIv0iAIv0iMKvEiPKPAiPaLAi/SIAi/SIwq8SI8o8CI9osCL9IgCL9IjrwGkVe2wIlQa/QAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1108010L0BBAAAB&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Lacri-lube eye ointment : 22</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1104020W0&amp;denomIds=11.4.2&amp;selectedTab=summary">Azelastine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Other anti-inflammatory preparations</td>
      <td>24</td>
      <td>0.50</td>
      <td>0.06</td>
      <td>0.08</td>
      <td>5.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1104020W0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Azelastine 0.05% eye drops : 12</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0409010A0&amp;denomIds=4.9.1&amp;selectedTab=summary">Apomorphine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>163</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>5.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0409010A0BCACAX&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">APO-go PEN 30mg/3ml solution for injection : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0409010A0BCADAZ&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">APO-go PFS 50mg/10ml inf pre-filled syringes : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Cranham Health Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1305020D0&amp;denomIds=13.5.2&amp;selectedTab=summary">Calcipotriol</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Preparations for psoriasis</td>
      <td>36</td>
      <td>0.56</td>
      <td>0.87</td>
      <td>0.08</td>
      <td>-3.82</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1305020D0BCAAAF&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Dovobet ointment : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1305020D0BEAAAI&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1305020D0BBAAAA&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Dovonex 50micrograms/g ointment : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1104020T0&amp;denomIds=11.4.2&amp;selectedTab=summary">Sodium cromoglicate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Other anti-inflammatory preparations</td>
      <td>24</td>
      <td>0.12</td>
      <td>0.67</td>
      <td>0.18</td>
      <td>-2.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1104020T0AAAJAJ&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye dps 0.3ml ud preservative free : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=1104020T0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye drops : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0702020F0&amp;denomIds=7.2.2&amp;selectedTab=summary">Clotrimazole</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Vaginal and vulval infections</td>
      <td>19</td>
      <td>0.63</td>
      <td>0.90</td>
      <td>0.10</td>
      <td>-2.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0702020F0AAAFAF&amp;denomIds=7.2.2&amp;selectedTab=summary" target="_blank">Clotrimazole 500mg pessaries : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0702020F0AAAGAG&amp;denomIds=7.2.2&amp;selectedTab=summary" target="_blank">Clotrimazole 10% vaginal cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0702020F0AAAEAE&amp;denomIds=7.2.2&amp;selectedTab=summary" target="_blank">Clotrimazole 200mg pessaries : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0702020F0AAAJAJ&amp;denomIds=7.2.2&amp;selectedTab=summary" target="_blank">Clotrimazole 2% cream : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0&amp;denomIds=6.2.1&amp;selectedTab=summary">Levothyroxine sodium</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1306</td>
      <td>Thyroid hormones</td>
      <td>1318</td>
      <td>0.99</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-2.58</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0AABWBW&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 25microgram tablets : 421</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0AABXBX&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 50microgram tablets : 466</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0AABZBZ&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 100microgram tablets : 414</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0AABYBY&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 75microgram tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0602010V0AAGAGA&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 50micrograms/5ml soln sugar free : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0407042Q0&amp;denomIds=4.7.4&amp;selectedTab=summary">Pizotifen malate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Prophylaxis of migraine</td>
      <td>34</td>
      <td>0.06</td>
      <td>0.65</td>
      <td>0.26</td>
      <td>-2.27</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHyklEQVR4nO3db4wdVR3G8e8sVflXBLFWtJVpG2grZaVACxWW1gCCTCEKLwrGxGAN8ZW+ZEyIr4wZQmKMvkEUEU2IfYECMhATDFsotrXdAoFaWloYEbUWA1aoloI9vvid691edt29e++dc+fO80lOtm269/72Zp85Z87MORM55xCRehgKXYCIlEeBF6kRBV6kRhR4kRpR4EVqRIEXqREFXqRGFHiRGlHgRWpEgRepkfIDH0W6l1ckkFmhC5B6i9P8OGA+sBBY4Nt8YDZwMnCS/+qAQ+Pam8CrwCu+/QnYV2TJv0r+ESolKn3xTBQ5nIvKfVPpBz7cy4ALgPN9WwD8EXh5XHsF+Cfwlm+HgAgLf6N9EPg48IlxbRFwFNgF7PRtDHihyJL/lPEz9jsFXnomTvNZwHnAamANFvQXgG3ADiyMLxVZcrSL7zkbWAqcA5yLHVQWA3v9+233bU8337cqFHjpGh/w5Vi4V2Nhex7YCIwC24osORKgriHgbOBC3y7ARgNPA0/6tr3IkrfLrq1sCrzMWJzm78NCvQYL+HnAc1i4N2IhKj3g0xGn+fux4I/41jg4PQI8CrxYZEnQCeY4zU/HRitHgZ1Flhzs9DUVeJk2H/ALaQ7Rh4FnaQZ8rMiSd0LV1wk/v7AC+Jxvp2Lh3wBsKSv8cZqfCdwMfAk4gp0CDQGfxOYybiuyJJ/p6yvwMinfC66gGfBl2DC4MUTfUWTJu6Hq66U4zT8CXAusw4b/v8TCP9aL8MdpvhD4FnAJ8GPg3iJL9rf8n/OBO4osuXym76PAy//4c93lwFXAZ7CJrzGaAX9mUAP+//jw3wDcCHwU+AVwX5Elu7vw2vOA24ArgAwL+qSjpDjNo04OOAp8zcVp/iEgAa4GLgP2AL8BfosFXJezxonTfD7W638RuzfgPmBDkSWvtvk6i4FvYJ/7d4EflTFpqMDXUJzmc4DPY73WEiDHJqpGiyx5K2RtVRKn+RLgJuwAcAA7UD4OPFtkyaGW/xsB87CD6xf8n78P/LzMm4UU+JrwE27XArdgl6geAO4HNtfxenQ3+TAPA5djp0LLsBuFXgPeAU4AzgD2YweFhwj0uSvwAy5O8xj4Kjbruxm4C9iokPdWnOYnAqdjt68fAf7aD5+5Aj+AfG++FuvNF9Cc9X0taGESnAI/QPw13EZvvhX4IXZerhWKAmi1XOX521kbvflC4G7goiJLDgQtTPqSeviKitN8Ac07sn6PnZuP9sN5ovQv9fAV4ieCrge+gt0Acg9wsXpzmS718H3OX/K5COvNr8Gul99Difd3y+BQ4PuUv6ljnW9/w0J+f+sNHSLt0JC+T/iefDE2ZF+H3bCxAbimyJIiYGkyQBT4gPz18hFslj0B/gE8CNxQZMnekLXJYNKQvkRxmp8ArAQuxYI+jM2w/xrIW5dDinSbAt9DcZqfhq1vHsFCfia2n9uTwCbg6apuGCHVpMB3kV862ei9R4ATgado7pu2WzPrEpICP0N+km0pzd77Emyv9EbvvandNdIivabAT9O4DRsbAV+B7aHeCPjviix5I1yFIlNT4CcRp/nJwMU0h+dLsA0bG8PzbUWWHA5XoUj7FHjP71t2Kc1z8LnY+vFNWMCf03ZPUnUdBd4vxzwFu0nkIPD3KWed+yDwcZofj23WuBK7bXUl8C7NcG/CnoiiCTYZKJ0Gfiv2DLBZ2LO+5mLPAttJs3fccczmfCUH3l8aOwfbdmgYO/c+A3gGWzO+FRue6/xbBl7Xh/Q+YOcCn8aGx8uBfdjlqc3F7Wsf7Hbg/fbKH8P2D1+EzZ4vwzbvfxt7osjz2FNRtgOFem+po56fw/swLsUOAKuK29feHN/68B7sDrM/ALuxp4X+BXgDOFxkifOXvT7g2/HAHGxJ6Fz/tfG00IXAaf77X8IOLruwgO/S44NFmoJM2sW3PjwHe2TRUmzByDyshz4V2+ETbM/vI1gPfRjbAXT/uPZnLNz7gNfVY4tMTbP0IjUyFLoAESmPAi9SIwq8SI10FPgoim5p+5sCnr/PqN7AqlZz1eqF6tXcSb2d9vCV+qCoXr1QvZqrVi9Ur+ZggReRClHgRWqk08Df1ZUqylO1eqF6NVetXqhezTOut/wbb0QkGA3pRWqkrX3poyi6DFsEc8A595Moiq7HFrDsdc79qhcFdmqCmr+MLZd91Dn3eNjq3qu1Xv9vdwI/dc5tCVrcJCb4jEeAVcAW59wTYat7rwnqXQ/MBnDOfS9ocZOIomgN8DXn3I3+7+uxhWQbnXNPTfd12u3hVznnMmzlGsBZzrk7gLPbfJ0yHVOzc+5e4E5slV0/OqZef1AdDVrR1Fp/L64D/g3065NsW+s9DgtP3z6U0zk3iu3h0PBh59x3sCXo09Zu4FtP+KswAXBMjVEUnQSsB34WppwptX6mwzR3xe1XrTWf4pz7AfDZEMVMQ2u9Q865b2Kj1aqYUfbamrTzQ6FVwOvADuzBCouAF51zD8ykgF6boOavA3uBx5xzm0PWNpHWep1zY344d7jPh/StvxcxcNA5d3fA0iY0Qb2rgQh40znXlzP2URR9Cvg2sAXrrK7ERiVPtDOk1yy9SI1oll6kRhR4kRpR4EVqRIEXqREFXqRGFHiRGlHgRWpEgRepEQVepEYUeJEaUeBFauS/NoQXZ+gNRYYAAAAASUVORK5CYII="></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F82674&amp;numIds=0407042Q0AAABAB&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Pizotifen 500microgram tablets : 2</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>